From: 40th International Symposium on Intensive Care & Emergency Medicine
 | 90-day mortality of medical condition | 90-day mortality of the remaining cohort | Relative risk (+95% CI) |
---|---|---|---|
Hematological malignancy | 66% (54/81) | 40% (309/765) | 1.51 (1.28-1.80); p<0.0001 |
Solid organ cancer | 49% (105/213) | 41% (258/633) | 1.21 (1.03-1.42); p=0.04 |
Metastatic solid organ cancer | 60% (34/58) | 42% (329/788) | 1.40 (1.11-1.77); p=0.02 |
End stage renal disease | 52% (56/107) | 42% (307/739) | 1.26 (1.03-1.54); p=0.045 |
Chronic obstructive pulmonary disease | 54% (45/83) | 42% (318/763) | 1.3 (1.05-1.61); p=0.04 |
No comorbidities | 11% (6/53) | 45% (357/793) | 0.25 (0.12-0.54); p<0.0001 |
Age >80 | 60% (51/85) | 41% (312/761) | 1.46 (1.20-1.78); p=0.001 |